Per Grybäck Selected Research

Per Grybäck Research Topics

6	Neoplasms (Cancer) 06/2023 - 04/2012
2	Neoplasm Metastasis (Metastasis) 11/2023 - 06/2023
2	Breast Neoplasms (Breast Cancer) 01/2023 - 01/2021
2	Carcinoma (Carcinomatosis) 01/2019 - 07/2013
1	Lymphatic Metastasis 11/2023
1	Thyroid Neoplasms (Thyroid Cancer) 11/2023
1	Squamous Cell Carcinoma of Head and Neck 01/2023
1	Neuroblastoma 01/2022
1	Pathologic Complete Response 01/2021
1	Alzheimer Disease (Alzheimer's Disease) 01/2020
1	Parathyroid Neoplasms (Parathyroid Neoplasm) 12/2019
1	Parkinson Disease (Parkinson's Disease) 01/2019
1	Hyponatremia 01/2019
1	Hypertension (High Blood Pressure) 01/2019
1	Fatigue 01/2019
1	Neutropenia 01/2019
1	Febrile Neutropenia 01/2019
1	Dyskinesias (Dyskinesia) 01/2019
1	Renal Cell Carcinoma (Grawitz Tumor) 06/2014
1	Gastric Fistula 12/2005

2	IodineIBA 11/2023 - 12/2019
2	Trastuzumab (Herceptin)FDA Link 01/2023 - 01/2021
2	Docetaxel (Taxotere)FDA Link 01/2023 - 01/2021
2	Ado-Trastuzumab EmtansineIBA 01/2023 - 01/2021
2	pertuzumabIBA 01/2023 - 01/2021
2	Sorafenib (BAY 43-9006)FDA Link 01/2019 - 07/2013
2	Tyrosine Kinase InhibitorsIBA 01/2019 - 06/2014
1	Biomarkers (Surrogate Marker)IBA 06/2023
1	RadiopharmaceuticalsIBA 01/2022
1	Hormones (Hormone)IBA 01/2021
1	Amyloid Precursor Protein Secretases (beta-Secretase)IBA 01/2020
1	EnzymesIBA 01/2020
1	Technetium Tc 99m Sestamibi (Cardiolite)FDA LinkGeneric 12/2019
1	PlatinumIBA 01/2019
1	LigandsIBA 01/2019
1	metabotropic glutamate receptor 4IBA 01/2019
1	vinflunineIBA 01/2019
1	Levodopa (L Dopa)FDA LinkGeneric 01/2019
1	Cisplatin (Platino)FDA LinkGeneric 07/2013
1	Somatostatin Receptors (Somatostatin Receptor)IBA 04/2012
1	1- (2- methylbenzoxazol- 6- yl)- 3- (1,5)naphthyridin- 4- yl ureaIBA 12/2005
1	Pentagastrin (Peptavlon)FDA Link 12/2005

2	Neoadjuvant Therapy 01/2023 - 01/2021
2	Therapeutics 01/2022 - 06/2014
1	Neck Dissection (Radical Neck Dissection) 01/2023
1	Radiotherapy 01/2022
1	Segmental Mastectomy (Lumpectomy) 01/2021